Skip to content

A Randomised Control Trial to evaluate the efficacy of Acupuncture and "sham-acupuncture" for migraine

Research on the conclusion of "no difference" of therapeutic effects between the acupuncture and sham-acupuncture for migraine

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10000807
Enrollment
Unknown
Registered
2010-03-08
Start date
2010-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

Group A:acupuncture(shallow puncture in meridian points)
Group B:acupuncture(normal puncture in meridian points)

Sponsors

Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. According to the diagnostic criteria for migraine with or without aura of International Headache Society (IHS) in 1988; 2. The migraine attacks 2-6 times in last 4 weeks; 3. The onset of migraine is before the age of 50; 4. The patient is diagnosed as migraine for at least 26 weeks before entering the study; 5. The migraine lasts for 4 to 72 hours without taking drugs in acute phase, or for more than 2 hours taking drugs at attack stage; 6. The patient is between 18 to 65 years old; 7. The patient is voluntary and agrees to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Unable to work (caused by severe migraine) for more than 4 days every month; 2. Special types of migraine, such as ophthalmoplegic migraine, hemiparalysis migraine, basilar migraine; 3. With epilepsy, stroke and other organic diseases in nervous system; 4. With history of psychiatric or taking antipsychotic drugs/antidepressant drugs; 5. The migraine is secondary to: (1) systemic diseases, such as disease of cardiovascular system, acute infection, hematopathy, endocrinal and metabolic disease, allergy, toxication; (2) diseases of ophthalmology and Otorhinolaryngology, such as glaucoma, tympanitis, paranasal sinusitis, pericoronitis of the wisdom tooth; (3) intracranial diseases, such as intracranial infection, cerebroma, subarachnoid hemorrhage; 6. The patient is within some special period, such as gravida, woman in lactation, drug addict; 7. Taking analgesics more than 3 days every month because of other chronic pain; 8. Receiving hormone therapy; 9. Has taken drugs preventing migraine in 6 months; 10. The patient has severe vital primary disease of cardiac and cerebral vessel system, liver, kidney, hematopoietic system and other systems.

Design outcomes

Primary

MeasureTime frame
number of migraine outbreak days per mont;

Secondary

MeasureTime frame
headache duration;quality of life;headache intensity;

Countries

China

Contacts

Public ContactJingjing Wang
wjj751@sina.com+86 13439630965

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026